| P50 | author | Stefan M. Pfister | Q39183179 |
| | Marc Remke | Q43153350 |
| | Marcel Kool | Q90637389 |
| | Paul A Northcott | Q91826566 |
| P2093 | author name string | J Lee | |
| | M D Taylor | |
| | K Gandhi | |
| | R C Castellino | |
| | M C Buss | |
| | M J Schniederjan | |
| P2860 | cites work | Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization | Q22010658 |
| | The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop | Q24297633 |
| | Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner | Q24336721 |
| | PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints | Q24527393 |
| | p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation | Q24596239 |
| | Molecular subgroups of medulloblastoma: the current consensus | Q24615271 |
| | Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy | Q24651380 |
| | In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 | Q27642888 |
| | Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. | Q27851485 |
| | Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 | Q28218453 |
| | Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity | Q28218469 |
| | Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci | Q28236937 |
| | Subgroup-specific structural variation across 1,000 medulloblastoma genomes | Q28271811 |
| | Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase | Q28283888 |
| | Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma | Q28284093 |
| | Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome | Q28298987 |
| | Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer | Q28388006 |
| | Altered neural cell fates and medulloblastoma in mouse patched mutants | Q28588056 |
| | Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations | Q30040534 |
| | Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma | Q30156001 |
| | Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. | Q33209208 |
| | Overexpressed TP73 induces apoptosis in medulloblastoma | Q33290650 |
| | Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features | Q33366431 |
| | Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis | Q33438165 |
| | Targeting p53 for Novel Anticancer Therapy | Q33655329 |
| | Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 |
| | FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma | Q34215755 |
| | G-protein-coupled receptors and cancer. | Q34606002 |
| | G protein-coupled receptor kinase 5 phosphorylation of hip regulates internalization of the chemokine receptor CXCR4 | Q35166206 |
| | Clonal selection drives genetic divergence of metastatic medulloblastoma | Q35784926 |
| | HDM2 promotes WIP1-mediated medulloblastoma growth. | Q35845228 |
| | Functional genomics identifies drivers of medulloblastoma dissemination | Q36296016 |
| | Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D | Q36326949 |
| | Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups | Q36460209 |
| | Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables | Q36476670 |
| | Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint | Q36841814 |
| | Medulloblastoma comprises four distinct molecular variants | Q36920479 |
| | A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. | Q37089440 |
| | Genetic variants and mutations of PPM1D control the response to DNA damage. | Q37396919 |
| | A review on CXCR4/CXCL12 axis in oncology: no place to hide. | Q38017493 |
| | Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. | Q39875833 |
| | Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1. | Q40263011 |
| | Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results | Q40636357 |
| | c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice | Q41589752 |
| | CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma | Q41760694 |
| | RETRACTED ARTICLE: Localized synovial hypertrophy in the anteromedial compartment of the osteoarthritic knee | Q42425290 |
| | WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function. | Q42676343 |
| | SDF-1 alpha induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. | Q43700208 |
| | Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients | Q44608794 |
| | p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease | Q44635070 |
| | Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial | Q45120061 |
| | Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure? | Q46648311 |
| | Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies | Q46853172 |
| | Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas. | Q48506060 |
| | Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood | Q48948841 |
| | PPM1D is a potential target for 17q gain in neuroblastoma | Q52828743 |
| | Surveillance scanning of children with medulloblastoma. | Q52883048 |
| | Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. | Q53286039 |
| | Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine. | Q53322778 |
| | Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice. | Q53346673 |
| | The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis. | Q53595739 |
| | Medulloblastoma: a potpourri of distinct entities. | Q55462236 |
| | Adult medulloblastoma comprises three major molecular variants. | Q55463035 |
| | Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. | Q55468802 |
| | c-Myc promoter activation in medulloblastoma. | Q55472620 |
| | Wip1 Phosphatase Modulates ATM-Dependent Signaling Pathways | Q61849111 |
| | The role of receptor kinases and arrestins in G protein-coupled receptor regulation | Q74578170 |
| | Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival | Q81325774 |
| | Medulloblastoma | Q84749666 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | medulloblastoma | Q1333608 |
| P304 | page(s) | 1126-1140 | |
| P577 | publication date | 2014-03-17 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants | |
| P478 | volume | 34 | |